Gilead Sciences, Inc. revenue breakdown overview

Gilead Sciences, Inc. revenue for the last year amounted to 27.12 B USD, the most of which — 27.12 B USD — came from its highest performing source at the moment, Innovative Medicines, the year earlier bringing 27.28 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Gilead Sciences, Inc. 19.44 B USD, and the year before that — 18.88 B USD.